deltatrials

Nova Scotia Health Authority Clinical Trials

Sponsors / Nova Scotia Health Authority

Nova Scotia Health Authority appears as lead sponsor on 163 trial records in ClinicalTrials.gov. The portfolio currently includes 28 recruiting studies, 11 active non-recruiting studies, and 72 completed studies. 19 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include funding constraints, slow or insufficient recruitment. Cumulative planned enrollment across all listed trials is 23,865 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.

163
Total Trials
28
Recruiting
11
Other Active
72
Completed
19
Terminated / Withdrawn
23,865
Total Enrollment

Termination reasons: Other37% · Funding32% · Recruitment26% · PI/or_Site5%

Recent Terminations

  • NCT04714164 Phase NA Stopped Sep 2023
    Generalized Anxiety Disorder
    "We had difficulty with participation in the study for our initial Zoom CBT group."
  • NCT03240614 Phase NA Stopped Mar 2023
    Hypoxemia
    "Pandemic and loss of funding"
  • NCT03804814 Phase NA Stopped Oct 2021
    Hepatitis C
    "Pandemic impacted ability to recruit and enroll"
  • NCT04363892 Phase NA Stopped Jun 2021
    Breast Cancer
    "The PI resigned"
  • NCT04005235 Stopped Mar 2020
    Diaphragm Elevated
    "Covid-19 pandemic, aerosol generating procedures"
  • NCT03410355 Phase NA Stopped May 2019
    Osteoarthritis, Hip
    "Health Canada no longer allowed use of BMAC"
  • NCT03464604 Stopped Oct 2018
    Melanoma
    "COVID forced the termination of this study. No impact on participants already enrolled."
  • NCT02621853 Phase NA Stopped Mar 2017
    Steatosis
    "Principal Investigator is also study sponsor. Dr. Alwayn is leaving NSHA and Canada for a new appointment in Europe."
  • NCT01927614 Stopped Jul 2015
    Heart Transplantation
    "PI resigned from the department of medicine, dalhousie university and the nova scotia health authority effective august 24 2015"
  • NCT01948089 Phase NA Stopped Nov 2014
    Chronic Phase Stroke Patients

Active Trials (11 total)

Top Conditions

Eating disorders (4) Anesthesia (3) Bipolar disorder (3) Osteoarthritis (3) Prostate cancer (3) Breast cancer (2) Cancer (2) Degenerative lumbar disc disease (2) Depression (2) Glaucoma (2)

Top Locations

Halifax, Canada (137) Dartmouth, Canada (2) Edmonton, Canada (2) Montréal, Canada (2) Leuven, Belgium (1) Bedford, Canada (1) Calgary, Canada (1) Hamilton, Canada (1) Kentville, Canada (1) London, Canada (1)